Bespoke Extracts Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Bespoke Extracts's earnings have been declining at an average annual rate of -8.1%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 84.1% per year.
Anahtar bilgiler
-8.1%
Kazanç büyüme oranı
10.0%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 6.0% |
Gelir büyüme oranı | 84.1% |
Özkaynak getirisi | n/a |
Net Marj | -110.1% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Güncelleme yok
Recent updates
Gelir ve Gider Dağılımı
Bespoke Extracts nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 1 | -1 | 2 | 0 |
31 Mar 24 | 1 | -1 | 2 | 0 |
31 Dec 23 | 1 | -1 | 2 | 0 |
30 Sep 23 | 1 | -2 | 2 | 0 |
30 Jun 23 | 0 | -3 | 3 | 0 |
31 Mar 23 | 0 | -4 | 4 | 0 |
31 Dec 22 | 0 | -4 | 4 | 0 |
30 Sep 22 | 0 | -3 | 3 | 0 |
30 Jun 22 | 0 | -2 | 2 | 0 |
31 Mar 22 | 0 | -1 | 2 | 0 |
31 Dec 21 | 0 | 0 | 1 | 0 |
30 Nov 21 | 0 | -1 | 1 | 0 |
31 Aug 21 | 0 | -1 | 1 | 0 |
31 May 21 | 0 | -1 | 1 | 0 |
28 Feb 21 | 0 | -4 | 4 | 0 |
31 Dec 20 | 0 | -1 | 1 | 0 |
30 Nov 20 | 0 | -4 | 4 | 0 |
31 Aug 20 | 0 | -5 | 4 | 0 |
31 May 20 | 0 | -5 | 4 | 0 |
29 Feb 20 | 0 | -2 | 1 | 0 |
30 Nov 19 | 0 | -2 | 1 | 0 |
31 Aug 19 | 0 | 3 | -3 | 0 |
31 May 19 | 0 | 1 | -1 | 0 |
28 Feb 19 | 0 | -1 | 1 | 0 |
30 Nov 18 | 0 | -3 | 2 | 0 |
31 Aug 18 | 0 | -8 | 7 | 0 |
31 May 18 | 0 | -7 | 6 | 0 |
28 Feb 18 | 0 | -9 | 9 | 0 |
30 Nov 17 | 0 | -8 | 8 | 0 |
31 Aug 17 | 0 | -7 | 7 | 0 |
31 May 17 | 0 | -5 | 5 | 0 |
28 Feb 17 | 0 | 0 | 0 | 0 |
30 Nov 16 | 0 | 0 | 0 | 0 |
31 Aug 16 | 0 | 0 | 0 | 0 |
31 May 16 | 0 | -1 | 0 | 0 |
29 Feb 16 | 0 | -1 | 0 | 0 |
30 Nov 15 | 0 | -1 | 0 | 0 |
31 Aug 15 | 0 | -1 | 0 | 0 |
31 May 15 | 0 | 0 | 0 | 0 |
28 Feb 15 | 0 | 0 | 0 | 0 |
30 Nov 14 | 0 | 0 | 0 | 0 |
31 Aug 14 | 0 | 0 | 0 | 0 |
31 May 14 | 0 | 0 | 0 | 0 |
28 Feb 14 | 0 | 0 | 0 | 0 |
Kaliteli Kazançlar: BSPK is currently unprofitable.
Büyüyen Kar Marjı: BSPK is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: BSPK is unprofitable, and losses have increased over the past 5 years at a rate of 8.1% per year.
Büyüme Hızlandırma: Unable to compare BSPK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: BSPK is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (12.4%).
Özkaynak Getirisi
Yüksek ROE: BSPK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.